Paju A - Search Results

1

Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3.

Koistinen H, Paju A, Koistinen R, Finne P, Lövgren J, Wu P, Seppälä M, Stenman UH. Koistinen H, et al. Among authors: paju a. Prostate. 2002 Feb 1;50(2):112-8. doi: 10.1002/pros.10039. Prostate. 2002. PMID: 11816019

2

Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.

Bjartell A, Paju A, Zhang WM, Gadaleanu V, Hansson J, Landberg G, Stenman UH. Bjartell A, et al. Among authors: paju a. Prostate. 2005 Jun 15;64(1):29-39. doi: 10.1002/pros.20236. Prostate. 2005. PMID: 15651064

3

Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.

Paju A, Stenman UH. Paju A, et al. Crit Rev Clin Lab Sci. 2006;43(2):103-42. doi: 10.1080/10408360500523852. Crit Rev Clin Lab Sci. 2006. PMID: 16517420 Review.

4

Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.

Paju A, Hotakainen K, Cao Y, Laurila T, Gadaleanu V, Hemminki A, Stenman UH, Bjartell A. Paju A, et al. Eur Urol. 2007 Dec;52(6):1670-9. doi: 10.1016/j.eururo.2007.01.096. Epub 2007 Feb 5. Eur Urol. 2007. PMID: 17306443

5

Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma.

Hotakainen K, Lintula S, Ljungberg B, Finne P, Paju A, Stenman UH, Stenman J. Hotakainen K, et al. Among authors: paju a. J Mol Diagn. 2006 Nov;8(5):598-603. doi: 10.2353/jmoldx.2006.060076. J Mol Diagn. 2006. PMID: 17065429 Free PMC article.

6

Expression and characterization of trypsinogen produced in the human male genital tract.

Paju A, Bjartell A, Zhang WM, Nordling S, Borgström A, Hansson J, Stenman UH. Paju A, et al. Am J Pathol. 2000 Dec;157(6):2011-21. doi: 10.1016/S0002-9440(10)64840-7. Am J Pathol. 2000. PMID: 11106574 Free PMC article.

7

Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma.

Paju A, Jacobsen J, Rasmuson T, Stenman UH, Ljungberg B. Paju A, et al. J Urol. 2001 Mar;165(3):959-62. J Urol. 2001. PMID: 11176522

8

Application of proteomic technology in identifying pancreatic secretory trypsin inhibitor variants in urine of patients with pancreatitis.

Valmu L, Paju A, Lempinen M, Kemppainen E, Stenman UH. Valmu L, et al. Among authors: paju a. Clin Chem. 2006 Jan;52(1):73-81. doi: 10.1373/clinchem.2005.056861. Epub 2005 Oct 27. Clin Chem. 2006. PMID: 16254194

9

Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.

Paju A, Vartiainen J, Haglund C, Itkonen O, von Boguslawski K, Leminen A, Wahlström T, Stenman UH. Paju A, et al. Clin Cancer Res. 2004 Jul 15;10(14):4761-8. doi: 10.1158/1078-0432.CCR-0204-03. Clin Cancer Res. 2004. PMID: 15269150

10

Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.

Hotakainen K, Haglund C, Paju A, Nordling S, Alfthan H, Rintala E, Stenman UH. Hotakainen K, et al. Among authors: paju a. Eur Urol. 2002 Jun;41(6):677-85. doi: 10.1016/s0302-2838(02)00125-2. Eur Urol. 2002. PMID: 12074787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters